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Abstract
Background: To examine the effect of the natural antimicrobial peptide human β-defensin-3 (hBD-3), on the
migration of a head and neck cancer cell line in vitro using microfabrication and soft-lithographic techniques.
Methods: TR146 cancer cells were seeded in Petri dishes with microfabricated wells for cell migration assays. Total 54
cell islands were used of various shape and size and experimental media type. Cell migration assays were analyzed in
six group media: Dulbecco’s modified medium (DMEM); DMEM with vascular endothelial growth factor (VEGF);
Conditioned media of human embryonic kidney cells (HEK 239) expressing hBD-3 via transfected cloned pcDNA3 as
CM/hBD-3; CM/hBD-3 + VEGF; conditioned medium from non-transfected HEK 239 (not expressing hBD-3) as control
(CM); and the last group was CM+VEGF. Cell islands were circular or square and varied in size (0.25 mm2, 0.125 mm2,
and 0.0625 mm2). Cell islands were imaged at t = 0 h, 3 h, 6 h, and 24 h.
Results: The results show cancer cell islands that originally were smaller had higher migration indices. There was no
difference of MIs between circular and square cell islands. MIs at the end point were significantly different among the
groups except between CM and CM-hBD-3+ VEGF.
Conclusions: VEGF enhanced cancer cell migration. The combination of DMEM and VEGF showed a synergistic effect
on this phenomenon of cancer cell migration. Conditioned medium with hBD-3 suppressed cancer cell migration.
hBD-3 suppressed VEGF enhancement of TR146 cancer cell migration.
Keywords: Head and neck cancer, Cancer cell migration, Human beta defensin, Migration index, Micro-fabricated cell
islands
Background
In the head and neck region, two of the most common
types of cancer are cancer of the oral cavity and cancer
of the oropharynx. More than 35,000 Americans are
diagnosed each year with oral or oropharyngeal cancer,
which will cause over 8,000 deaths, killing roughly one
person per hour. Ninety to ninety-five percent of those
cancers are squamous cell carcinomas [1].
Cancer metastasis to vital organs is the main cause of
mortality in cancer patients. Growth rate and metastatic
potential in different types of cancer cells are important
clinically for both selection of treatment and for
prognosis. The metastatic potential of a cancer cell is
related not only to the complex biological cascade of
autocrine, paracrine, and endocrine signaling processes
of cell-cell and cell-substrate interactions, but also to
inherited ability of cell movement [2]. There are many
signaling pathways involved in cell migration, including
actin and microtubule dynamics, cell-cell and cell-
extracellular matrix adhesion, and intracellular traffick-
ing of proteins [3]. Preventing the process of metastasis,
the spread of cancer cells from a primary tumor to a
secondary site, is cardinal therapeutic approach for treat-
ing cancer patients.
In the 1980s, endogenous antimicrobial peptides
(AMPs) were found at high concentrations in the granules
of neutrophils and macrophages. These antimicrobial pep-
tides were named “defensins”. Human β-defensin (hBD)
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formly in the epithelium of the oral cavity. Specifically,
human beta defensin-3 (hBD-3) is a small, cationic peptide
that primarily is known for its antimicrobial, antifungal,
and antiviral properties [4]. β-defensins, initially identified
as broad-spectrum antimicrobial peptides, increasingly
have been observed to exhibit numerous other in vitro
and in vivo activities that do not always relate directly to
host defense. In addition to direct antimicrobial activity,
β-defensins exhibit potent chemotactic activity for a var-
iety of innate immune cells and stimulate other cells to
secrete cytokines [5].
The expression of β-defensins in cancer is controver-
sial for example; diminished hBD-1 expression has been
reported for renal and prostate cancer [6,7]and for basal
cell carcinoma [8]. Loss of expression of hBD-1, hBD-2,
and hBD-3 in oral squamous cell carcinoma has also
been reported [9]. In contrast, elevated hBD-1 expres-
sion has been reported to occur within renal cell
carcinomas [10]. Lung cancer patients have elevated
hBD-1 in their serum, along with upregulated hBD-2
[11]. Human β-definsin-3 expression has been shown
to be increased in vulvar squamous cell carcinoma
[12]. Data on β-defensin expression in oral squamous
cell carcinoma (OSCC) also are in conflict. Low levels
of hBD-2 expression in OSCC have been linked to poor
differentiation. In contrast, other studies have reported
increased hBD-2 expression in OSCC compared with
normal epithelial cells [13,14].
hBD-3 is chemotactic for immature dendritic cells,
memory T cells, and mast cells. There is increasing evi-
dence that human β-defensins are differentially regulated
in cancers such as OSCC. Overexpression of hBD-3, but
not hBD-1 and hBD-2, has been shown in pre-malignant
cells in carcinoma in situ lesions. hBD-2 is associated
with tumor-associated macrophage (TAM) trafficking in
oral cancer [15]. The function of overexpression of hBD-
3 in carcinoma in situ and in malignant cells is unclear
and its contribution to cancer cell migration is un-
known. Novel anticancer agents are needed when resist-
ance exists against conventional chemotherapy. Natural
antimicrobial peptides or synthetic derivatives may be
used as novel strategies against neoplastic growth and
may represent a novel family of anticancer agents. How-
ever, future research is needed to understand the role of
antimicrobial peptides in cancer and to develop potential
anticancer drugs.
Currently, the most relevant methods of determining
the metastatic potential of neoplasia are in vivo assays
involving tumor cell implantation in immunodeficient
animals. These methods, however, are expensive and the
results may depend on the site or route of cancer cell
entry. Use of in vitro methodology to predict the meta-
static potential of cancer cells can be useful forpredicting those cancer cell behaviors in vivo. At
present, common methods of in vitro models of tumor
cell invasion use Mitrgel assays which have a filter in be-
tween two chambers. Tumor cells are dispersed in the
upper chamber while chemotaxants are dispersed in the
lower chamber. A barrier is removed and the cells mi-
grate over a set amount of time through the gel, which
is then stained and the tumor cells counted. The draw-
back of this method is that the observation time is
randomly selected and the concentration of the chemo-
tactic agents diffusing into the gel may not consistent as
a function of time over a multiple experiments [16].
Microfabrication combined with soft lithographic
methods is a useful platform for patterning proteins and
cells. Soft lithography refers to a family of techniques for
fabricating or replicating structures using “elastomeric
stamps, molds, and conformable photomasks.” Elasto-
meric materials are used, most notably Polydimethylsi-
loxane (PDMS). PDMS has several properties that make
it suited for patterning proteins and cells. PDMS is bio-
compatible, is permeable to gases, and is used in cell
cultures. It is optically transparent. Because it is elasto-
meric, it conforms to non-planar surfaces well. Soft
lithography that is derived from photolithography and
associated techniques which offers tools for micropat-
terning that complement and extend conventional
fabrication methods for biological research [17]. By using
these microfabrication and soft lithography techniques;
we examined the effect of a natural antimicrobial pep-
tide, human β-defensin-3, on a human head and neck
cell line (TR146) migration in vitro.
Methods
Cancer cell culture
TR146 cell line is a metastatic human buccal tumor cell
line isolated from the neck. The TR146 cell line was
maintained at 5% CO2; 37°C in Dulbecco’s modified
media (DMEM) with 10% fetal bovine serum (Invitro-
gen, Carlsbad, CA) and 100 IU/mL penicillin, 100μg/mL
streptomycin, and 0.25μg/mL amphotericin B. The
cultures were split at sub-confluence (70-80%) 1:4 seed-
ing at 3x104cells/cm2.
Human β-Defensin-3
Human embryonic kidney 293 cells (HEK293; ATCC,
Manassas, VA) were maintained in Dulbecco’s modified
media (DMEM) supplemented with 10% fetal bovine
serum (Invitrogen, Carlsbad, CA) and antibiotics
(100 IU/mL penicillin, 100μg/mL streptomycin, 0.25μg/
mL amphotericin B). To generate a stable HEK 293 cell
line expressing hBD-3, the coding region of hBD-3 was
cloned into pcDNA3 (Invitroge) and transfected into
HEK293 cells using Lipofectamine 2000 following the
manufacturer’s protocol (Invitrogen) [18]. HEK293 cells
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jected to hBD-3 enzyme-linked immunosorbent assay
(ELISA) analysis to determine hBD-3 secretion and con-
centration [19]. To prepare conditioned media of hBD-3,
HEK/hBD-3 were cultured in DMEM 10%FBS overnight
and then the cells were cultured in serum-free DMEM
for 24 h. The medium (CM/hBD-3) was collected and
centrifuged at 5,000xg to remove cell debris and again
the concentration of hBD-3 was determine by ELISA
and solution was diluted to 20 ng/mL. 3 ml of the condi-
tioned medium with 20 ng of hBD-3 was used as the
CM/hBD-3 solution. Conditioned media derived from
HEK293 cells without hBD-3 transfection was used as
controls (CM).
Fabrication of PDMS membranes by soft lithography
containing microarrays
Polydimethylsiloxane (PDMS) membranes were obtained
using a standard combination of photolithography and
soft lithography techniques [17]. AutoCAD (Autodesk,
Inc., San Rafael, CA) microarrays were used to obtain
photomasks (Advance Reproductions, North Andover,
MA). The array patterns on a silicon wafers were spin-
coated with a negative photoresist SU-8 2075 (Microchem
Corp, Newton, MA). The photoresist was then processed
with the photomask to produce a negative template. The
polymer PDMS (Sylgard 184, Dow Corning, Midland, MI)
was used to create a positive template by spin-coating and
curing at 80 0C. The resulting membranes were about
100 μm thick. The membranes were attached to a PDMS
ring (60 mm inner diameter, 4 mm thick) for easy hand-
ling and stability.
Development of cell islands
Individual square or circular cell islands of three sizes
(0.25 mm2, 0.125 mm2, and 0.0625 mm2) were arranged
into microarrays in the PDMS membrane. The thickness
of the PDMS membrane was approximately 100 μm. A
PDMS ring 4 mm thick was attached to the membrane
to enable safe handling and to create wells in which the
suspended cells were deposited. The membranes were
sterilized in 100% ethanol (Fisher Scientific, Pittsburgh,
PA) overnight, then transferred to a fresh 50 mm Petri-
dish (BD, Franklin Lakes, NJ) and allowed to adhere to
the dish surface. Two milliliters of 1X phosphate buf-
fered saline (PBS) were pipetted into the well and placed
under vacuum for one hour. The PBS was aspirated and
was replaced with 1%w/v BSA in 1x PBS for 30 min at
room temperature in a sterile environment and then
aspirated. The BSA prevents the cells from adhering to
the PDMS surface. Figure 1 is a schematic of cell island
development using PDMS membrane.
Fibronectin (20 mg/mL in PBS) was added and incu-
bated onto the cell-contact surfaces for 1 h at 37 0 C and5% CO2. The fibronectin (FN) solution was aspirated
and 1.0x 106 TR146 cells were seeded on the membrane
and allowed to attach overnight in order to form conflu-
ent circular or square “cell islands” with areas of
0.25 mm2, 0.125 mm2, and 0.0625 mm2 each. The
PDMS membranes were then removed and cell islands
gently washed with phosphate-buffered saline (PBS, Invi-
trogen). Two milliliters of fibronectin were added and
the Petri dishes incubated for 1 h of 37 0 C and 5% CO2.
The fibronectin solution was then aspirated and experi-
mental media was added to the cells. Cell migration
studies also were conducted without the use of fibronec-
tin. In the experiments without fibronectin, only DMEM
was used as the experimental media.
Cell migration assay
Two-dimensional cell migration from well-formed con-
sisting of confluent cell islands was studied in 60 mm
Petri dishes for 24 h since the doubling time for TR 146
cells in culture is 1.5 day. Islands were imaged at t = 0 h
(initial time point) and at t = 3, 6, 12, and 24 h (end time
point). We chose a 24-h end point because this repre-
sented the optimal time that minimized cell proliferation
effect on island expansion.
Phase contrast images of the cells islands were taken
with an Olympus IX71 inverted microscope (Olympus,
Japan) using an UPlanFl 10x objective and the software
ImagePro (Media Cybernetics, Bethesda, MD).
TR146 cancer cell island migration was studied under
different solution environments. Six groups were
designed in this study: Dulbecco’s modified medium
(DMEM); DMEM with vascular endothelial growth fac-
tor (VEGF); Conditioned media of human embryonic
kidney cells (HEK 239) expressing hBD-3 via transfected
cloned pcDNA3 (CM/hBD-3); CM/hBD-3 +VEGF; con-
ditioned medium from non-transfected HEK 239 (not
expressing hBD-3) as control (CM); and CM+VEGF.
Analyzing cell islands
Phase contrast images of each initial cell island area and
the areas from the same cell island at different time
intervals were analyzed. Image J (Rasband WS, ImageJ,
U. S. National Institutes of Health, Bethesda, MD, USA,
http://rsb.info.nih.gov/ij) was used to quantify the cell is-
land areas. The area occupied by each cell island was
measured immediately after the removal of PDMS
membrane (t = 0 h) and then after 3 h, 6 h, and 24 h of
migration. Migration was quantified as the area of island
at any given time normalized to the initial area, with
margins of cell islands tracked manually. This parameter
was termed Migration Index (MI). It is a more accurate
way of quantifying migration from cell islands because it
takes into account the initial size differences of the
islands, allowing us to compare migration of various
Figure 1 Steps for cell island fabrication using PDMS membranes.
Figure 2 Migration indices of square cell islands (0.0625, 0.125,
and 0.25 mm2) in DMEM medium as function of time.
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expressed as mean ± standard deviation. Experiments
were performed in triplicate and at least 9 cell islands
(n = 9) in total were used for each cell island shape and
size and experimental media type. The migration charac-
teristics of islands of these cells were studied in vitro by
monitoring their migratory behavior.
Statistical analysis
Cell migration assays were averaged across replicate
experiments. Statistical analyses of the data were per-
formed by analysis of variance (ANOVA) to examine the
general trends, and individual comparisons were per-
formed by using Tukey’s test. A p-value of <0.05 was
considered as statistically significant. Three variables
were analyzed at different time intervals: 3 h, 6 h, and
24 h. The three variables are original cell island sizes
(0.25 mm2, 0.125 mm2, and 0.0625 mm2), cell island
shapes (square and circle), and the six different experi-
mental media.
Results and discussion
Every effort was made to develop uniform monolayer
cell islands. A cell density distribution curve was gener-
ated with square islands. Average cell count correlate
linearly with island size, thus indicating that consistent
cell density was maintained for all islands.Figure 2 shows smaller cell islands had significantly
larger MI (p< 0.01) compared to the larger islands at
3 h, 6 h, and 24 h points. The smallest square island
(0.0625 mm2) showed an average MI of 1.60 ± 0.21 in
DMEM environment while the largest square island
(0.25 mm2) showed an MI of 1.30 ± 0.09 after 6 h. When
comparing 24 h results in the same medium, MI was
3.71 ± 0.42 for the smallest square island category while
Figure 4 Migration indices of the 0.25 mm2 cell islands in the
different experimental media.
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2.95 ± 0.37. They were statistically different at the three
time intervals.
Figure 3 shows the migration index of 0.25 mm2 circle
and square islands with and without fibronectin. There
was no statistical difference between the Migration Indices
of the two shape design, circle vs. square in the same sized
category. The p-values of the difference of the MI between
the circle and square cell islands with fibronectin at 3, 6,
and 24 h were 0.885, 0.8888, and 0.866 respectively. The
p-values of the difference of the MI between the circle and
square islands without fibronectin at 3, 6, and 24 h were
0.8786, 0.88491, and 0.8759 respectively. However, there
was a significant difference between with and without
fibronectin groups. Only 0.25 mm2 circle cell island data
were analyzed for comparison of the effect of different
media on cancer cell migration.
Figure 4 is a graph showing the different cell migration
profiles in different conditions. DMEM+VEGF group had
the highest MI followed by DMEM group. CM/HBD-3
had the lowest migration index and was statistically differ-
ent from all the other groups (P ≤ 0.01). Figures 5, 6, 7,
8, 9 and 10 are typical micro-images of cancer cell mi-
gration of 6 groups as function of time and condition.
The in vitro microfabrication and soft lithography-based
migration assays for this experiment allowed for the ac-
complishment of the following: (a) the inclusion of differ-
ent patterns of microarrays within the same stencil, (b)
the ability to generate behavior of rapid migration of cells
and (c) ease of use and analysis. This migration model was
successfully used to investigate migration of a TR146Figure 3 Cell migration with and without fibronectin using
square and circle cell islands at different time intervals.
DMEMSF = square cell islands in DMEM, treated with fibronectin;
DMEMCF= circular cell islands in DMEM, treated with fibronectin;
DMEMSNF = square cell islands in DMEM without fibronectin
treatment; DMEMCNF= circular cell islands in DMEM without
fibronectin treatment. Cell island size was 0.25 mm2.cancer cell line under various experimental conditions.
The model would be used for future investigation to
quantify the effect of heterotypic interaction of the TR146
cell islands with other cells.
The larger cell islands depict a greater final area com-
pared the smaller islands, but this must be studied in the
proper context, i.e., these larger islands already had a
much larger initial area compared to the smaller islands.
However, interestingly, the MI of smaller TR146 cell
islands is higher compared to larger cell islands. The
lower MI of larger cell islands can be due to local cell-Figure 5 Phase contrast images of 0.25 mm2 TR146 cell islands
in DMEM at different time intervals. White bar on the upper left
is 100 μm. (Top left: 0 h; top right: 3 h; bottom left: 6 h; bottom
right: 24 h).
Figure 6 Phase contrast images of 0.25 mm2 TR146 cell islands
in DMEM+VEGF at different time intervals. Phase contrast
images of 0.25 mm2 TR146 cell islands in DMEM+VEGF at different
time intervals. White bar on the upper left is 100 μm. (Top left: 0 h;
top right: 3 h; bottom left: 6 h; bottom right: 24 h)(Top left: 0 h; top
right: 3 h; bottom left: 6 h; bottom right: 24 h).
Figure 8 Phase contrast images of 0.25 mm2 TR146 cell islands
in CM+VEGF at different time intervals. White bar on the upper
left is 100 μm. (Top left: 0 h; top right: 3 h; bottom left: 6 h; bottom
right: 24 h).
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gration behavior within the cell islands. These in vitro
results may reflect the behavior of TR146 tumors clinic-
ally. It is possible that tumor size may have a strongFigure 7 Phase contrast images of 0.25 mm2 TR146 cell islands
in CM at different time intervals. White bar on the upper left is
100 μm. (Top left: 0 h; top right: 3 h; bottom left: 6 h; bottom right:
24 h).impact on metastatic migration of cancer cells. However,
the TR146 cell line may also behave differently in an
in vitro monolayer- and filter-based assays environment
compared to the more three-dimensional in vitro envir-
onment. Clearly, significant future investigation will
needed to resolve these questions.Figure 9 Phase contrast images of 0.25 mm2 TR146 cell islands
in CM+hBD at different time intervals. White bar on the upper
left is 100 μm. (Top left: 0 h; top right: 3 h; bottom left: 6 h; bottom
right: 24 h).
Figure 10 Phase contrast images of 0.25 mm2 TR146 cell
islands in CM+VEGF+hBD at different time intervals. White bar
on the upper left is 100 μm. (Top left: 0 h; top right: 3 h; bottom left:
6 h; bottom right: 24 h).
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sizes and shapes, as it normalizes each area to its initial
value. Circle and square islands are different in shapes
and perimeters. The effect of shape was quantified by
calculating the migration indices of islands of each shape
at 3 time intervals. While circular and square-shaped
islands retained the effect of size, i.e., increasing MI with
decreasing island sizes, there was no significant differ-
ence in migration between circle and square islands
whether they were in the presence or absence of fibro-
nectin. These results indicate that amount of migration
is independent relative to the cell island shape, which
can allow flexibility in future experimental designs in
using this type of migration model.
The standard deviations of cell MI were large with
small cell islands, therefore, we chosen to use large size
with circle shape islands to analyze the effect of different
environments on cancer cell migration.
When the cells were exposed to DMEM with or with-
out fibronectin, the cells without fibronectin migrated
less than cells with fibronectin, which was expected, as
fibronectin is an important molecule in extracellular
matrix that enhances cell adhesion and migration. The
TR146 cell islands were established on FN-coated sur-
faces which enhance cell-cell adhesion inside the cell
island and simulate an extracellular environment outside
the cell island area. From the baseline area measure-
ments of the media containing DMEM and CM (condi-
tioned media); the addition of VEGF increased the
migration rates of the cells. VEGF is known to stimulatetumor angiogenesis in vivo and thereby to facilitate
tumor growth and metastases. VEGF has been shown to
stimulate endothelial cell mitogenesis and cell migration,
as well as other non-neoplastic cell types. VEGF concen-
tration in the tumor tissues showed a relationship with
the clinical stage and histologic grade of the tumor [20].
Interestingly, the most amount of migration occurred
with DMEM+VEGF, even more than CM+VEGF,
which implies some migratory inhibition factors present
in CM that prevent maximal potential migration of the
cells when exposed to VEGF. Further studies will be
needed to determine if there are other factors are in the
CM from HEK 239 that inhibits migration.
With the conditioned media from HEK239 cells of over-
expressed hBD-3, migration rates were markedly decreased
in both media with and without VEGF compared to CM
with and without VEGF, respectively. CM/hBD-3 resulted
minimal migration, while CM/hBD-3+VEGF resulted mi-
gration levels that were equivalent to CM alone. This im-
plies a possible inhibitory effect by hBD-3 on the VEGF
pathway that promotes cell migration.
Conclusions
The platform technology we have developed for this study
provides advantages to continuously measure cancer cell
migration as a function of time. The migration of TR 146
cancer cell islands is strongly dependent on island sizes,
but not on island shapes. TR146 cell migration was
promoted by both fibronectin and VEGF. Cancer cell mi-
gration was inhibited in all media containing hBD-3 com-
pared to all respective media without hBD-3, including
VEGF, a known potent stimulator of cell migration.
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